Cost analysis of ardeparin versus enoxaparin for the prophylaxis of deep vein thrombosis after knee arthroplasty

Clinical Therapeutics

Volumn 20, Issue 2, 1998, Pages 347-351

  Wade, William E ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

Ardeparin; Deep vein thrombosis prophylaxis; Enoxaparin; Knee arthroplasty

Indexed keywords

ARDEPARIN; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ARTICLE; COST BENEFIT ANALYSIS; COST CONTROL; DEEP VEIN THROMBOSIS; DRUG COST; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; KNEE ARTHROPLASTY; LUNG EMBOLISM;

EID: 0031777679     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(98)80098-2     Document Type: Article

References (12)

1. Stulberg BN, Insoll JN, Williams GW, Ghelman B Deep vein thrombosis following total knee replacement: An analysis of six hundred and thirty-eight arthroplasties. J Bone Jt Surg Am. 1984;66: 194-201.
2. Leclerc JR, Geerts WH, Desjardins L, et al. Prevention of venous thromboembolism after knee arthroplasty. A randomized, double-blind trial comparing enoxaparin with warfarin. Ann Intern Med. 1996;124:619-626.
3. National Institute of Health Consensus Conference. Prevention of venous thromboembolism and pulmonary embolism. JAMA. 1986;256:744-749.
4. Clagett GP, Anderson FA, Heit J, et al. Prevention of venous thromboembolism. Chest. 1995;106(Suppl):312S-334S.
5. Colwell CW Jr, Spiro TE, Trowbridge AA, et al. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep venous thrombosis after elective knee arthroplasty. Enoxaparin Clinical Trial Group. Clin Orthop. 1995;321: 19-27.
6. Anderson DR, O'Brien BJ, Levine MN, et al. Efficacy and cost of low-molecular-weight heparin compared with standard heparin for the prevention of deep vein thrombosis after total hip arthroplasty. Ann Intern Med. 1993;119:1105-1112.
7. Menzin J, Colditz G. Regan M, et al. Cost-effectiveness of enoxaparin versus low-dose warfarin in the prevention of deepvein thrombosis after total hip replacement surgery. Arch Intern Med. 1995; 155: 757-764.
8. Mandami MM, Weingarten CM, Stevenson JG. Thromboembolic prophylaxis in moderate-risk patients undergoing elective abdominal surgery: Decision and cost-effectiveness analysis. Pharmacotherapy. 1996;16:1111-1127.
9. Levine MN, Gent M, Hirsh J, et al. Ardeparin (low-molecular-weight heparin) vs graduated compression stockings for the prevention of venous thromboembolism. A randomized trial in patients undergoing knee surgery. Arch Intern Med. 1996;156:851-856.
10. Heit JA, Berkowitz SD, Bona R, et al. Efficacy and safety of low molecular weight heparin (ardeparin sodium) compared to warfarin for the prevention of venous thromboembolism after total knee replacement surgery: A double-blind, dose-ranging study. Thromb Haemost. 1997;77: 32-38.
11. Leclerc JR, Geerts WH, Desjardins L, et al. Prevention of deep vein thrombosis after major knee surgery - a randomized double-blind trial comparing a low molecular weight heparin fragment (enoxaparin) to placebo. Thromb Haemost. 1992; 67:417-423.
12. Fauno P, Suomalainen O, Rehnberg V, et al. Prophylaxis for the prevention of venous thromboembolism after total knee arthroplasty. A comparison between unfractionated and low-molecular-weight heparin. J Bone Jt Surg Am. 1994;76: 1814-1818.